GlobeNewswire

VistaJet Launches the Most Extensive Children's Private Travel Program

Dela

Adventures in the Sky: interactive entertainment, educational activities and tailored parties in the sky to create a young traveler's dream voyage

  • Parties in the sky with world-renowned party planners
  • The first children-trained cabin crew in private aviation
  • Expert led approach based on data-driven insight and observations

LONDON, June 04, 2018 (GLOBE NEWSWIRE) -- VistaJet, the first and only global business aviation company, today announced the launch of Adventures in the Sky, the most extensive travelers' program designed especially for children.

With one in four of VistaJet flights in 2017 having a child on-board*, offering activities dedicated to young travelers is proving increasingly important.

Created for passengers aged one to 16 years old, Adventures in the Sky** will turn VistaJet cabins into playrooms and party venues. Children will be actively engaged with storytelling illustration books, personalized explorer backpacks and family activity hampers, and serviced by children-trained hostesses, offering them special menus and a host of interactive adventures.

Parties in the Sky
At the forefront of Adventures in the Sky is a series of themed parties, created in collaboration with world-renowned event-planners Sharky and George. Each activity is hosted on-board by an expert team, to make young fliers' time in the air truly memorable.

Alice in the Sky takes children down the rabbit hole and into a magical world where boys and girls can host their own Mad Hatter's Tea Party, play flamingo croquet and the Contrariwise game.

The Secret Mission trains recruits as secret service agents to unravel an international criminal operation. Guided by an in-flight Spy Chief, new agents will receive Kingsman-inspired training in the art of writing and decrypting code, taking fingerprints, crime scene techniques and secret messaging.

For the young cinephile, Movies in the Sky will include a film crew equipped with camera, editing and green screen equipment to create their own movie from script writing and casting to make-up, acting, filming and special effects. Children can act out their favorite blockbuster or bring new ideas to life.

Adventure Packs
VistaJet has created a series of activity packs. Explorer Backpacks, personalized to the individual child's age and their travel destination, are designed to be used both on-board and for days afterwards. For the whole family, personalized Activity Hampers will be prepared, full of activities to create together.

To entertain its younger passengers, VistaJet has also created a series of six hand-illustrated sticker-books where children can follow the adventures of protagonists Miloh and Scarlet.

Private Dining
VistaJet's Private Dining chefs have created a new menu to appeal to children from anywhere in the world and all the dishes provide the healthy requirements their parents expect.

A Child Expert On-Board
With many families traveling with a nanny, VistaJet has taken the unprecedented step to train all its Cabin Hostesses with the prestigious early years education and childcare institute, Norland College. The dedicated training program covers child development and behaviors, understanding family dynamics and recognizing times of need for families when traveling.

VistaJet is the first private aviation company to take these steps to provide the best service for every passenger.

* Identified as children born after June 1, 2001. 
** Additional children services are dedicated to VistaJet's Program members. Prices on application. Services are available from multiple global locations, and in a large number of languages.

www.vistajet.com/children

Information : 
Jennifer Farquhar | VistaJet | T: +44 203 617 3077 | jennifer.farquhar@vistajet.com 

About VistaJet
VistaJet is the first and only global aviation company. On its fleet of over 70 silver and red business jets, VistaJet has flown corporations, governments and private clients to 187 countries, covering 96% of the world. Founded in 2004 by Thomas Flohr, the company pioneered an innovative business model where customers have access to an entire fleet whilst paying only for the hours they fly, free of the responsibilities and asset risks linked to aircraft ownership. VistaJet's signature Program membership offers customers a bespoke subscription of flight hours on its fleet of mid and long-range jets, to fly them anytime, anywhere. Customers can also request Direct one-off flights through the industry's first end-to-end booking app or a 24/7 global team.  
More VistaJet information and news at vistajet.com

About Sharky and George
Sharky & George is a London based children's events company that specializes in fun for all ages, through awesome games, creative activities and imaginative experiences. The team is made up of inspirational and energetic rock stars who really 'get' children and take huge pride in making others happy. 
From regularly partying at No.10 Downing Street to entertaining 850 children in the garden of Buckingham Palace, Sharky & George has worked on a broad range of events. Creating private parties in Qatar, Switzerland, New York and throughout Europe, Sharky & George has worked with different cultures, and learned how to best to entertain children from around the globe.

About Norland College
Norland was founded in 1892 by Emily Ward who recognized the need for early years care and education to be formalized. Founded on the motto Love Never Faileth, the college has a child-centered approach to training both its full-time students and in consultancy. Graduates trained at Norland College are employed worldwide as Norland Nannies and Maternity Nurses through their in-house employment agency, Norland Agency.

A photo accompanying this announcement is available at 

http://www.globenewswire.com/NewsRoom/AttachmentNg/e76a68e0-2260-42dd-80f7-2041a5b18614

http://www.globenewswire.com/NewsRoom/AttachmentNg/4de3602e-0da9-4e9d-8a9e-785c55f0a236

http://www.globenewswire.com/NewsRoom/AttachmentNg/f4ac2060-f0d6-450c-9ef8-635995954e4b




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: VistaJet Ltd via Globenewswire

Om

GlobeNewswire



Följ GlobeNewswire

Abonnera på våra pressmeddelanden.

Senaste pressmeddelandena från GlobeNewswire

Arcoma AB: Investerarmöten våren 201915.2.2019 08:46:00Pressmeddelande

15 februari 2019 PRESSRELEASE Arcoma har som ambition att fortsätta öka sitt aktieägarfokus och kontinuerligt förbättra kommunikationen med aktieägare. Under våren 2019 kommer Arcoma medverka på flertalet investerarmöten där aktuella händelser och aktiviteter presenteras. Här ges en ökad inblick i bolagets vision och strategier samt en möjlighet till att ställa frågor till bolagets ledning. SvD Börsplus Temadag "Dubblare" Dag, tid och plats: 5 mars, kl. 13.00, GT 30, Grev Turegatan 30, Stockholm Stockholm Corporate Finance Life Science event Dag, tid och plats: 14 mars, kl. 07.30, Berns, Kammarsalen, Stockholm Redeyes Medtech & Diagnostics event Dag, tid och plats: 14:e maj, Redeye, Mäster Samuelsgatan 42, Stockholm För ytterligare information, vänligen kontakta: Arcomas VD Jesper Söderqvist, Telefon: +46 470 70 69 81, E-mail: jesper.soderqvist at arcoma.se Om Arcoma Arcoma, med lång erfarenhet av branschen, är en ledande leverantör av integrerade digitala röntgensystem med hög kvalite

Corline Biomedical AB: Första patient doserad med Renaparin®15.2.2019 08:42:00Pressmeddelande

Corline Biomedical AB ("Corline" eller "Bolaget") meddelar idag att man inkluderat första patienten i fas 1-studien RENAPAIR 01. Patienten inkluderades vid transplantationsavdelningen på Uppsala Akademiska sjukhus. Renaparin® är en produkt under utveckling för att förbättra njurtransplantation. I Corlines studie RENAPAIR 01 utvärderas produkten med avseende på tolerabilitet och säkerhet. Studien öppnades för patientrekrytering i slutet av 2018 och första patient är nu doserad och inkluderad i studien. Totalt skall 18 patienter rekryteras och när de 4 första patienterna är utvärderade i Uppsala, öppnas också Karolinska Universitetssjukhuset i Huddinge för rekrytering till studien. Henrik Nittmar, VD i Corline Biomedical AB, kommenterar "Det händer mycket i Corline för tillfället och alla arbetar hårt för att målbilden i bolaget skall uppfyllas. Det gäller såväl vår interna organisation som våra externa samarbetspartners. Därför är det extra roligt när vi når avgörande milstolpar i utvec

Corline Biomedical AB: Rekryterar Lars Olsson som Head of CMC14.2.2019 12:44:00Pressmeddelande

Corline Biomedical AB ("Corline" eller "Bolaget") meddelar idag att man rekryterat Lars Olsson till den nyinrättade tjänsten som Head of CMC (Chemistry, Manufacturing & Control). Lars Olsson hade tidigare samma tjänst hos Wilson Therapeutics AB, som under 2018 förvärvades av amerikanska Alexion. Lars Olsson kommer att ansvara för Corlines samtliga aktiviteter inom tillverkning och kontroll relaterat till bolagets läkemedelsprodukter, med särskilt fokus på Renaparin® inför kommande fas 2- och fas 3-utveckling. I slutet av 2018 meddelade Corline att patientrekryteringen startar i bolagets fas 1-studie RENAPAIR 01, där produkten Renaparin®, som är under utveckling för att förbättra utfallet av njurtransplantation, utvärderas med avseende på tolerabilitet och säkerhet. Därmed tog en ny utvecklingsfas vid i bolaget i vilken alltmer resurser fokuseras på att förbereda den fortsatta kliniska utvecklingen av produkten genom fas 2 och fas 3 i syfte att slutligen kunna registrera produkten för k

Arcoma AB: Canon och Arcoma tecknar distributörsavtal för Turkiet14.2.2019 10:38:00Pressmeddelande

14 februari 2019 Canon Medical Systems i Turkiet och Arcoma har tecknat ett distributörsavtal som gör att Canon kommer att kunna sälja Arcomas produkter i Turkiet från och med den 15 februari 2019. Canon är sedan tidigare återförsäljare för Arcomas produkter i Nordamerika och utvalda länder i Europa. Detta samarbete utökas nu till Turkiet som är det första land i Canons Asien organisation att välja Arcoma som en formell partner. "Att vi stärker och formaliserar samarbetet med Canon även i Turkiet är ännu ett erkännande av Arcoma som leverantör av högkvalitativa röntgensystem. Canon i Turkiet förbereder ett flertal större upphandlingar till sjukhus där Arcomas lösningar ingår. Avtal som detta ingår i Arcomas strategi att utöka med nya försäljningskanaler och att expandera till nya länder för att skapa framtida tillväxt." kommenterar Arcomas VD, Jesper Söderqvist. För ytterligare information, vänligen kontakta: Arcomas VD Jesper Söderqvist, Telefon: +46 470 70 69 81, E-mail: jesper.soder

Karolinska Development's portfolio company OssDsign raises SEK 64m and aims for listing on Nasdaq First North12.2.2019 09:00:00Pressmeddelande

STOCKHOLM, February 12, 2019. Karolinska Development's portfolio company OssDsign announces today the closing of a private placement of SEK 64 million. Swedish private investors and the French investment management company Alto Invest have taken part in the private placement. OssDsign will now begin the process towards a listing on Nasdaq First North in 2019. The proceeds from the private placement will be used for continued sales expansion in Europe and the US of OssDsign regenerative implant solutions for improved healing of bone defects. Moreover, funds will be used for entering new markets, primarily preparing for market introduction in Japan where the company in parallel to the regulatory process will initiate pre marketing activities. With ethical committee approval already in place, leading surgeons in Japan can start building experience with the OssDsign technology prior to regulatory approval and launch. OssDsign prepares for a listing on Nasdaq Stockholm First North in 2019.

Karolinska Development's portfolio company OssDsign raises SEK 64m and aims for listing on Nasdaq First North12.2.2019 09:00:00Pressmeddelande

STOCKHOLM, February 12, 2019. Karolinska Development's portfolio company OssDsign announces today the closing of a private placement of SEK 64 million. Swedish private investors and the French investment management company Alto Invest have taken part in the private placement. OssDsign will now begin the process towards a listing on Nasdaq First North in 2019. The proceeds from the private placement will be used for continued sales expansion in Europe and the US of OssDsign regenerative implant solutions for improved healing of bone defects. Moreover, funds will be used for entering new markets, primarily preparing for market introduction in Japan where the company in parallel to the regulatory process will initiate pre marketing activities. With ethical committee approval already in place, leading surgeons in Japan can start building experience with the OssDsign technology prior to regulatory approval and launch. OssDsign prepares for a listing on Nasdaq Stockholm First North in 2019.

I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.

Besök vårt pressrum